These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 15234400)
21. [Should we use clopidogrel instead of ticlopidine in elective coronary angioplasty?]. Baralis G; Steffenino G; Dellavalle A; La Scala E; Uslenghi E Ital Heart J Suppl; 2003 Sep; 4(9):766-70. PubMed ID: 14635395 [TBL] [Abstract][Full Text] [Related]
22. Variability in response to clopidogrel: where is the threshold for 'low response'? Dániel A; Pintér T; Horváth IG; Komócsi A Eur Heart J; 2007 Feb; 28(4):515-6; author reply 516. PubMed ID: 17289747 [No Abstract] [Full Text] [Related]
23. [Predictive elements and prevention of myocardial damage during angioplasty/stenting]. Bossi I; Savonitto S; Cavallini C; Delgado A; Pirola R; Klugmann S Ital Heart J Suppl; 2002 Mar; 3(3):275-85. PubMed ID: 12040843 [TBL] [Abstract][Full Text] [Related]
24. Distal filter protection during percutaneous coronary intervention in native coronary arteries and saphenous vein grafts in patients with acute coronary syndromes. Pasquetto G; Reimers B; Favero L; Saccà S; Cernetti C; Napodano M; Piccolo P; Pascotto P Ital Heart J; 2003 Sep; 4(9):614-9. PubMed ID: 14635379 [TBL] [Abstract][Full Text] [Related]
25. Use of IIb/IIIa inhibitors in patients with in-stent restenosis treated with intracoronary gamma-radiation. Integrilin WRIST. Waksman R; Ajani AE; Gruberg L; Pinnow E; GebreEyesus A; Deible R; Satler LF; Pichard AD; Torguson R; Kent KM; Suddath W; Lindsay J Catheter Cardiovasc Interv; 2004 Jun; 62(2):162-6. PubMed ID: 15170704 [TBL] [Abstract][Full Text] [Related]
27. High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention. Mangiacapra F; De Bruyne B; Muller O; Trana C; Ntalianis A; Bartunek J; Heyndrickx G; Di Sciascio G; Wijns W; Barbato E JACC Cardiovasc Interv; 2010 Jan; 3(1):35-40. PubMed ID: 20129566 [TBL] [Abstract][Full Text] [Related]
28. Elevated plasma fibrinogen rather than residual platelet reactivity after clopidogrel pre-treatment is associated with an increased ischemic risk during elective percutaneous coronary intervention. Ang L; Thani KB; Ilapakurti M; Lee MS; Palakodeti V; Mahmud E J Am Coll Cardiol; 2013 Jan; 61(1):23-34. PubMed ID: 23287370 [TBL] [Abstract][Full Text] [Related]
29. Dual antiplatelet therapy for more than 12 months after percutaneous coronary intervention: insights from the Guthrie PCI Registry. Harjai KJ; Shenoy C; Orshaw P; Boura J Heart; 2009 Oct; 95(19):1579-86. PubMed ID: 19549619 [TBL] [Abstract][Full Text] [Related]
30. [Levels of troponin I, tropoinin T, isoenzyme MB creatine kinase and myoglobins in blood serum for perioperative diagnosis of myocardial infarction in patients after coronary artery bypass graft surgery with extracorporeal circulation]. Andres J; Stepień E; Szajna-Zych M; Drwiła R; Zietkiewicz M; Sadowski J; Kapelak B; Dziatkowiak A Folia Med Cracov; 2001; 42(4):263-71. PubMed ID: 12815787 [TBL] [Abstract][Full Text] [Related]
34. Troponin I elevation and cardiac events after percutaneous coronary intervention. Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677 [TBL] [Abstract][Full Text] [Related]
35. Contemporary use of antiplatelet therapies in percutaneous coronary interventions. Saw J; Moliterno DJ Coron Artery Dis; 2003 Aug; 14(5):373-80. PubMed ID: 12878902 [No Abstract] [Full Text] [Related]
36. Elective percutaneous coronary intervention using broad-spectrum antiplatelet therapy (eptifibatide, clopidogrel, and aspirin) alone, without scheduled unfractionated heparin or other antithrombin therapy. Denardo SJ; Davis KE; Tcheng JE Am Heart J; 2005 Jan; 149(1):138-44. PubMed ID: 15660045 [TBL] [Abstract][Full Text] [Related]
37. Clopidogrel use in diabetic patients with new stents. Cardiovasc J Afr; 2008; 19(4):232. PubMed ID: 18776976 [No Abstract] [Full Text] [Related]
38. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM; Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975 [TBL] [Abstract][Full Text] [Related]